Merck & Co., Inc.
Merck
MRK · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $65B
- Assets
- $136.9B
- SEC filing
- DEF 14A
- Filed
- April 8, 2026
Executive Compensation
Compensation reported for Merck’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Robert M. Davis
Chairman, Chief Executive Officer And President
$20.8M
Reported total
- Salary
- $1,645,302
- Stock awards
- $12,102,838
- Incentives
- $2,326,500
- Option awards
- $3,380,004
- Other
- $1,343,201
Dean Li
M.D., Ph.d. Executive Vice President And President, Merck Research Laboratories
$8.9M
Reported total
- Salary
- $1,460,000
- Stock awards
- $4,296,864
- Incentives
- $1,368,640
- Option awards
- $1,199,991
- Other
- $567,386
Caroline Litchfield
Executive Vice President And Chief Financial Officer
$7.5M
Reported total
- Salary
- $1,173,214
- Stock awards
- $3,580,681
- Incentives
- $1,099,800
- Option awards
- $1,000,008
- Other
- $660,382
Jennifer Zachary
Executive Vice President And General Counsel
$5.9M
Reported total
- Salary
- $1,062,217
- Stock awards
- $2,685,571
- Incentives
- $995,749
- Option awards
- $750,002
- Other
- $367,039
Sanat Chattopadhyay
Executive Vice President And President, Merck Manufacturing Division
$5.4M
Reported total
- Salary
- $982,170
- Stock awards
- $2,363,261
- Incentives
- $920,710
- Option awards
- $660,004
- Other
- $482,263
Robert M. Davis
Chairman, Chief Executive Officer And President
$20.8M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed April 8, 2026.
- Salary
- $1.6M
- Stock Awards
- $12.1M
- Option Awards
- $3.4M
- Incentives
- $2.3M
- Other
- $1.3M
Historical Compensation
Robert M. Davis total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,645,302 | $12,102,838 | $20,797,845 |
| 2024 | $1,623,874 | $13,077,541 | $23,186,064 |
| 2023 | $1,603,091 | $9,997,585 | $20,273,287 |
Named Executive Officers
Robert M. Davis
Chairman, Chief Executive Officer And President
Merck · MRK
$20.8M
FY 2025 · DEF 14A
Caroline Litchfield
Executive Vice President And Chief Financial Officer
Merck · MRK
$7.5M
FY 2025 · DEF 14A
Sanat Chattopadhyay
Executive Vice President And President, Merck Manufacturing Division
Merck · MRK
$5.4M
FY 2025 · DEF 14A
Dean Li
M.D., Ph.d. Executive Vice President And President, Merck Research Laboratories
Merck · MRK
$8.9M
FY 2025 · DEF 14A
Jennifer Zachary
Executive Vice President And General Counsel
Merck · MRK
$5.9M
FY 2025 · DEF 14A
Source information
- Company
- Merck & Co., Inc.
- Ticker
- MRK · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- April 8, 2026
- SEC accession number
- 0001193125-26-147704
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company